Measurement of serum total and free prostate-specific antigen in women with colorectal carcinoma

We investigated the diagnostic value and the relationship with clinicopathological features of total and free prostate-specific antigen by measuring the concentrations of these markers in the sera of 75 women with colorectal carcinoma and in 30 healthy women. Measurements were performed by immunoradiometric assay which utilizes monoclonal and polyclonal anti-prostate-specific antigen antibodies; the lowest detection level for both markers was 0.01 ng ml−1. Free prostate-specific antigen levels were significantly higher in women with colorectal carcinoma than healthy women (P=0.006). The percentage of free prostate-specific antigen predominant (free prostate-specific antigen/total prostate-specific antigen >50%) subjects was 20% in colorectal carcinoma patients and 3.3% in healthy women (P=0.035). Cut-off values were 0.34 ng ml−1 for total prostate-specific antigen and 0.01 ng ml−1 for free prostate-specific antigen. In women with colorectal carcinoma, total prostate-specific antigen positivity was 20% and free prostate-specific antigen positivity was 34.6%. When compared to negatives, total prostate-specific antigen positive patients had a lower percentage of well-differentiated (P=0.056) and early stage (stages I and II) tumours (P=0.070). However, patients with predominant free prostate-specific antigen, had a higher percentage of well-differentiated (P=0.014) and early stage tumours (P=0.090) than patients with predominant bound prostate-specific antigen. In conclusion, although the sensitivity of free prostate-specific antigen predominancy is low (20%), in distinguishing women with colorectal carcinoma than healthy women, its specificity is high (96.7%). Free prostate-specific antigen predominancy tends to be present in less aggressive tumours. These findings may indicate clinical significance of preoperative measurement of serum total and free prostate-specific antigen in women with colorectal carcinoma

Leishmania isoenzyme polymorphisms in Ecuador: Relationships with geographic distribution and clinical presentation

Background: Determinants of the clinical presentation of the leishmaniases are poorly understood but Leishmania species and strain differences are important. To examine the relationship between clinical presentation, species and isoenzyme polymorphisms, 56 Leishmania isolates from distinct presentations of American tegumentary leishmaniasis (ATL) from Ecuador were analyzed. Methods: Isolates were characterized by multilocus enzyme electrophoresis for polymorphisms of 11 isoenzymes. Patients were infected in four different ecologic regions: highland and lowland jungle of the Pacific coast, Amazonian lowlands and Andean highlands. Results: Six Leishmania species constituting 21 zymodemes were identified: L. (Viannia) panamensis (21 isolates, 7 zymodemes), L. (V.) guyanensis (7 isolates, 4 zymodemes), L. (V.) braziliensis (5 isolates, 3 zymodemes), L. (Leishmania) mexicana (11 isolates, 4 zymodemes), L. (L.) amazonensis (10 isolates, 2 zymodemes) and L. (L.) major (2 isolates, 1 zymodeme). L. panamensis was the species most frequently identified in the Pacific region and was associated with several clinical variants of cutaneous disease (CL); eight cases of leishmaniasis recidiva cutis (LRC) found in the Pacific highlands were associated with 3 zymodemes of this species. Mucocutaneous leishmaniasis found only in the Amazonian focus was associated with 3 zymodemes of L. braziliensis. The papular variant of CL, Uta, found in the Andean highlands was related predominantly with a single zymodeme of L. mexicana. Conclusion: Our data show a high degree of phenotypic variation within species, and some evidence for associations between specific variants of ATL (i.e. Uta and LRC) and specific Leishmania zymodemes. This study further defines the geographic distribution of Leishmania species and clinical variants of ATL in Ecuador

Lower plate structure and upper plate deformational segmentation at the Sunda-Banda arc transition, Indonesia

The Sunda‐Banda arc transition at the eastern termination of the Sunda margin (Indonesia) represents a unique natural laboratory to study the effects of lower plate variability on upper plate deformational segmentation. Neighboring margin segments display a high degree of structural diversity of the incoming plate (transition from an oceanic to a continental lower plate, presence/absence of an oceanic plateau, variability of subducting seafloor morphology) as well as a wide range of corresponding fore‐arc structures, including a large sedimentary basin and an accretionary prism/outer arc high of variable size and shape. Here, we present results of a combined analysis of seismic wide‐angle refraction, multichannel streamer and gravity data recorded in two trench normal corridors located offshore the islands of Lombok (116°E) and Sumba (119°E). On the incoming plate, the results reveal a 8.6–9.0 km thick oceanic crust, which is progressively faulted and altered when approaching the trench, where upper mantle velocities are reduced to ∼7.5 km/s. The outer arc high, located between the trench and the fore‐arc basin, is characterized by sedimentary‐type velocities (Vp < 5.5 km/s) down to the top of the subducting slab (∼13 km depth). The oceanic slab can be traced over 70–100 km distance beneath the fore arc. A shallow serpentinized mantle wedge at ∼16 km depth offshore Lombok is absent offshore Sumba, where our models reveal the transition to the collisional regime farther to the east and to the Sumba block in the north. Our results allow a detailed view into the complex structure of both the deeper and shallower portions of the eastern Sunda margin

Sunda-Banda arc transition: incipient continent-island arc collision (Northwest Australia)

The eastern Sunda arc represents one of the few regions globally where the early stages of continent-arc collision can be studied. We studied along the western limit of the collision zone at the Sunda-Banda arc transition, where the Australian margin collides with the Banda island arc, causing widespread back arc thrusting. We present integrated results of a refraction/wide-angle reflection tomography, gravity modeling, and multichannel reflection seismic imaging using data acquired in 2006 southeast of Sumba Island. The composite structural model reveals the previously unresolved deep geometry of the collision zone. Changes in crustal structure encompass the 10 - 12 km thick Australian basement in the south and the 22 - 24 kmthick Sumba ridge in the north, where backthrusting of the 130 km wide accretionary prism is documented. The structural diversity along this transect could be characteristic of young collisional systems at the transition from oceanic subduction to continent-arc collision. Citation: Shulgin, A., H. Kopp, C. Mueller, E. Lueschen, L. Planert, M. Engels, E. R. Flueh, A. Krabbenhoeft, and Y. Djajadihardja (2009), Sunda-Banda arc transition: Incipient continent-island arc collision (northwest Australia), Geophys. Res. Lett., 36, L10304, doi: 10.1029/2009GL037533

No association for Chinese HBV-related hepatocellular carcinoma susceptibility SNP in other East Asian populations.

published_or_final_versio

Prognostic value of DNA flow cytometry in stomach cancer: a 5-year prospective study

The role of DNA flow cytometry in the prediction of prognosis for patients with stomach cancer remains to be defined. Thus we studied prospectively the role of DNA flow cytometry as a prognosis indicator in stomach cancer patients in a high-incidence area. Between November 1990 and December 1992, primary stomach cancer tissues were obtained from the surgical specimens from 217 patients (148 male, 69 female). DNA flow cytometric analyses of DNA ploidy and S-phase fraction were performed and the results were correlated with patient survival. The median age of the patients was 55 years (range 24–78). Aneuploid cell population was found in 114 of 217 samples (53%). Tumour S-phase fraction was obtained in 96 of 103 diploid tumours (93%) and 61 of 114 aneuploid tumours (54%). After median follow-up of 66.1 months, the patients with tumours with an S-phase fraction over 17% had significantly worse survival rates than patients with tumours with S-phase fractions of lower than 8% or 8–17% (45% vs 59% and 63% of patients surviving, P = 0.007). Tumour ploidy status did not correlate with patient survival. Multivariate analyses showed that the TNM stage remained the most important prognostic indicator. The tumour S-phase fraction was also an independent prognostic indicator (relative risk 2.300, 95% CI, 1.252–4.223). Tumour S-phase fraction obtained by DNA flow cytometry is an independent prognostic indicator for the survival of the patients with stomach cancer. © 1999 Cancer Research Campaig